TY - JOUR
T1 - Drug delivery systems and materials for wound healing applications
AU - Saghazadeh, Saghi
AU - Rinoldi, Chiara
AU - Schot, Maik
AU - Kashaf, Sara Saheb
AU - Sharifi, Fatemeh
AU - Jalilian, Elmira
AU - Nuutila, Kristo
AU - Giatsidis, Giorgio
AU - Mostafalu, Pooria
AU - Derakhshandeh, Hossein
AU - Yue, Kan
AU - Swieszkowski, Wojciech
AU - Memic, Adnan
AU - Tamayol, Ali
AU - Khademhosseini, Ali
N1 - Elsevier deal
PY - 2018/3/1
Y1 - 2018/3/1
N2 - Chronic, non-healing wounds place a significant burden on patients and healthcare systems, resulting in impaired mobility, limb amputation, or even death. Chronic wounds result from a disruption in the highly orchestrated cascade of events involved in wound closure. Significant advances in our understanding of the pathophysiology of chronic wounds have resulted in the development of drugs designed to target different aspects of the impaired processes. However, the hostility of the wound environment rich in degradative enzymes and its elevated pH, combined with differences in the time scales of different physiological processes involved in tissue regeneration require the use of effective drug delivery systems. In this review, we will first discuss the pathophysiology of chronic wounds and then the materials used for engineering drug delivery systems. Different passive and active drug delivery systems used in wound care will be reviewed. In addition, the architecture of the delivery platform and its ability to modulate drug delivery are discussed. Emerging technologies and the opportunities for engineering more effective wound care devices are also highlighted.
AB - Chronic, non-healing wounds place a significant burden on patients and healthcare systems, resulting in impaired mobility, limb amputation, or even death. Chronic wounds result from a disruption in the highly orchestrated cascade of events involved in wound closure. Significant advances in our understanding of the pathophysiology of chronic wounds have resulted in the development of drugs designed to target different aspects of the impaired processes. However, the hostility of the wound environment rich in degradative enzymes and its elevated pH, combined with differences in the time scales of different physiological processes involved in tissue regeneration require the use of effective drug delivery systems. In this review, we will first discuss the pathophysiology of chronic wounds and then the materials used for engineering drug delivery systems. Different passive and active drug delivery systems used in wound care will be reviewed. In addition, the architecture of the delivery platform and its ability to modulate drug delivery are discussed. Emerging technologies and the opportunities for engineering more effective wound care devices are also highlighted.
KW - UT-Hybrid-D
KW - Drug delivery
KW - Transdermal delivery
KW - Microtechnologies
KW - Nanotechnologies
KW - Wound healing
U2 - 10.1016/j.addr.2018.04.008
DO - 10.1016/j.addr.2018.04.008
M3 - Review article
VL - 127
SP - 138
EP - 166
JO - Advanced drug delivery reviews
JF - Advanced drug delivery reviews
SN - 0169-409X
ER -